Importance of and Satisfaction with Information about Their Disease in Cancer Patients
Hannah Eisfeld(Jena University Hospital), Jutta Hübner(Goethe University Frankfurt), Thorsten Schmidt(University of Tübingen), Andreas Hochhaus(Jena University Hospital), Karin Kastrati, Clara Dubois(Klinikum Magdeburg), Fabienne Bauer(Klinikum Magdeburg)
Cited by 21
Related Papers
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
|Leukemia|2022|3.8k
Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis
|The Lancet Neurology|2004|1.1k
Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial
|Leukemia|2016|849
Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial
|The Lancet Oncology|2012|505
Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure
|New England Journal of Medicine|2019|464